Home > Cardiology > ISTH 2020 > COVID-19 and Thrombosis > COVID-19 not associated with heightened VTE risk after discharge

COVID-19 not associated with heightened VTE risk after discharge

Presented By
Dr Matthias Engelen, University Hospital Leuven, Belgium
ISTH 2020
A study performed in Belgium revealed a rather low incidence of venous thromboembolism (VTE) in discharged COVID-19 patients, and so data do not warrant a recommendation for prescription of extended thromboprophylaxis on a regular basis [1]. As the use of low-molecular-weight heparin (LMWH) appears to be linked to a better prognosis for hospitalised COVID-19 patients, every COVID-19 patient at University Hospital Leuven receives LWMH at prophylactic dosage, with ICU patients receiving an intermediate dose [2]. Yet, limited evidence is available on the incidence of VTE in discharged patients after COVID-19 hospitalisation, and whether extended prophylactic therapy is necessary. To this end, Dr Matthias Engelen (University Hospital Leuven, Belgium) and colleagues evaluated data from 133 adult COVID-19 patients. Participants were screened with venous ultrasound (VUS), and their C-reactive protein (CRP) and D-...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on